(£) GBP (Default)
  • ($) USD
  • (€) EUR
  • ($) AUD
  • ($) CAD
  • ($) NZD
Pharma Lab Global

15% off first order with code: 1storder

Pharma Lab Global
99%+ Quality Guaranteed
Pharma Lab Global
Pay by crypto get 10% discount
Pharma Lab Global
Shipping Protection
Pharma Lab Global
Fast Order Process

FTPP Adipotide Peptide Vial Canada

Research has found that the FTPP Adipotide Peptide can contribute to the reduction of fat tissue, adipose tissue and improved glucose levels. Treatment with adipotide could lead to a reversal of obesity which could reduce the chance of cardiovascular disease and diabetes.


SKU PLG: FTPP vial Categories ,


FTPP Adipotide Peptide Vial

Adipotide, or FTPP, is an investigational weight loss therapy that targets fat cells’ blood supply.

Adipotide is a novel medicine that has shown considerable potential in obesity research. FTPP Adipotide Peptide Vial Canada, originally developed to treat cancer, has shown promise in tests for reducing body weight.

Adipotide (also known as FTPP or pro-apoptotic peptide) destroys fat cells by cutting off their blood supply. The peptide is selective because it can distinguish between fat cells and blood vessels throughout the body. In animal studies, the FTPP peptide not only helped them lose weight but also improved insulin sensitivity and reduced the consequences of type 2 diabetes.


Molecular Formula: C152H252N44O42
Sequence: H-Cys-Lys-Gly-Gly-Arg-Ala-Lys-Asp-Cys-Gly-Gly-Asp-(Lys-Leu-Ala-Lys-Leu-Ala-Lys)2
Molecular Weight: 2611.41 g / mol
Physical Appearance: White Lyophilised Solid
Solubility: Water Soluble

Size: 2mg | 10mg


Fat loss

Adipotide’s Canada phase I clinical trials began in 2011 to assess the drug’s ability to kill fat cells. To test this theory, Canada researchers used rhesus monkeys. They discovered that giving animals Adipotide caused apoptosis in WAT blood vessels (white adipose tissue).

As a result, fat cells died due to a lack of blood supply, resulting in rapid weight loss, reduced BMI, and better insulin resistance. In addition, the FTPP Adipotide peptide medication led to weight loss and improved eating habits in the rhesus monkeys during vitro testing. Adipotide-treated monkeys ate less food than non-treated monkeys [1].

The peptide may be delivered to fat cell blood vessels via the protein receptor prohibitin. Prohibitin is found in just two types of cells: white fat and cancer cells. Also, Adipotide interacts with this protein. Assuming prohibitin is found only in fat vasculature and cancer tissue, it must then identify a fat-specific target for medicinal and diagnostic purposes [2].

Cancer research

Adipotide’s target molecule, prohibitin, has been linked to cancer [3]. To grow and metastasize, cancer cells require a lot of blood supply. Canada Studies performed on targeted prohibitin in cancer cells may allow for advanced cancer therapies that do not harm surrounding tissues.

Insulin resistance

Glucose tolerance is a word used to describe elevated blood sugar levels. Blood tests are used to detect and confirm the problem. A glucose tolerance test involves consuming a quantity of sugar and then evaluating the blood sugar levels. Glucose tolerance is a surrogate for diabetes, with greater glucose tolerance signifying diabetes.

Exercising and dieting can help lower blood sugar levels, but it takes effort and commitment. Their effect also takes time. Uncontrolled hyperglycemia usually leads to type 2 diabetes, requiring medications like metformin and sometimes insulin. Adipotide is a peptide that quickly improves glucose tolerance without weight gain.

Also, FTPP Adipotide peptide reduces glucose tolerance without affecting weight, which is crucial. That is, it is necessary to lose fat, not weight. These results pave the possibility for new diabetic treatments and help explain how diabetes develops.

There is some debate over whether Adipotide induces fat loss directly or whether it just reduces food consumption, which results in indirect fat loss. Most likely, Canada clinical studies have found that Adipotide is responsible for fat reduction on a direct basis. In supporting this concept, the peptide affects glucose tolerance without affecting fat cell density [4].


Adipotide is primarily studied for weight loss and diabetes. The protein specifically targets cells in fat-supply blood vessels, killing them and the fat cells they supply, thus resulting in weight loss and a reduction in body mass index in FTPP treated animals. FTPP Adipotide Peptide Vial targets blood vessels and is known as an anti-angiogenic peptide. Anti-angiogenic compounds are now being studied for cancer treatment. The role of Adipotide in cancer research is limited but promising.


[1] https://pubmed.ncbi.nlm.nih.gov/ 22072637/

[2] https://pubmed.ncbi.nlm.nih.gov/ 15133506/

[3] https://pubmed.ncbi.nlm.nih.gov/ 22049339/

[4] https://pubmed.ncbi.nlm.nih.gov/ 22733798/

Buy FTPP Adipotide Peptide vial

Pharma Lab Global Canada is one of the best locations to purchase high purity FTPP Adipotide for research use. Pharma Lab Global is a trusted supplier of peptides and sarms worldwide. You have the option to buy FTPP Adipotide Nasal Spray and FTPP Adipotide Pre Mixed peptide. Buy FTPP Adipotide Peptide from Pharma Lab Global Canada today!


DISCLAIMER: All products sold by Pharma Lab Global are for research and laboratory use only. These products are not designed for use or consumption by humans or animals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such. By purchasing from our Website the buyer accepts and acknowledges the risks involved with handling of these products. All articles and product information provided on this Website are for informational and educational purposes only. Handling and use of these products should be restricted to suitably qualified professionals.

Additional information


2mg Vial, 10mg Vial, Kit = 2mg vial, bac water, syringes, Kit = 10mg vial, bac water, syringes